Thomas S. Griffith

Affiliated with

Research Area

Biography

Thomas S. Griffith has not added Biography.
If you are Thomas S. Griffith and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 5	Year
Publication title	2023
Publication title	2023
Publication title	2023
Publication title	2023
Publication title Cited by 23	2017

Other Publications

Article	Year
Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8(+) T cells produce active immune unresponsiveness. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 12023355	2002
Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma. Cancer research\| PubMed ID: 12036919	2002
TRAIL: a mechanism of tumor surveillance in an immune privileged site. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 12391182	2002
Cell death and immune privilege. International reviews of immunology\| PubMed ID: 12424841	2002
Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer research\| PubMed ID: 12499252	2002
Apoptosis, tolerance, and regulatory T cells--old wine, new wineskins. Immunological reviews\| PubMed ID: 12752676	2003
The topoisomerase I inhibitor topotecan increases the sensitivity of prostate tumor cells to TRAIL/Apo-2L-induced apoptosis. Cancer chemotherapy and pharmacology\| PubMed ID: 12811515	2003
Plasmacytoid dendritic cell-derived IFN-alpha induces TNF-related apoptosis-inducing ligand/Apo-2L-mediated antitumor activity by human monocytes following CpG oligodeoxynucleotide stimulati... Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 12817000	2003
Structure/function analysis of the murine CD95L promoter reveals the identification of a novel transcriptional repressor and functional CD28 response element. The Journal of biological chemistry\| PubMed ID: 12855690	2003
Tumor necrosis factor-related apoptosis-inducing ligand: a novel mechanism for Bacillus Calmette-Guérin-induced antitumor activity. Cancer research\| PubMed ID: 15150089	2004
Human B cells express functional TRAIL/Apo-2 ligand after CpG-containing oligodeoxynucleotide stimulation. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 15240676	2004
Inhibition of the NF-kappaB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cells. Cancer gene therapy\| PubMed ID: 15332116	2004
Expression of TNF-related apoptosis-inducing ligand (TRAIL) in megakaryocytes and platelets. Experimental hematology\| PubMed ID: 15539085	2004
Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells. Journal of leukocyte biology\| PubMed ID: 15582984	2005
CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature\| PubMed ID: 15744305	2005
Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 15771957	2005
Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L. Blood\| PubMed ID: 16037389	2005
Histone deacetylase inhibitors modulate renal cell carcinoma sensitivity to TRAIL/Apo-2L-induced apoptosis by enhancing TRAIL-R2 expression. Cancer biology & therapy\| PubMed ID: 16096370	2005
Histone deacetylase inhibitors modulate the sensitivity of tumor necrosis factor-related apoptosis-inducing ligand-resistant bladder tumor cells. Cancer research\| PubMed ID: 16397266	2006
Neisseria gonorrhoeae delays the onset of apoptosis in polymorphonuclear leukocytes. Cellular microbiology\| PubMed ID: 16803582	2006
TRAIL deficiency delays, but does not prevent, erosion in the quality of "helpless" memory CD8 T cells. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 16818756	2006
Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma. Journal of pediatric surgery\| PubMed ID: 16863850	2006
A vision of cell death: Fas ligand and immune privilege 10 years later. Immunological reviews\| PubMed ID: 16972907	2006
Induction of protective immunity to RM-1 prostate cancer cells with ALVAC-IL-2/IL-12/TNF-alpha combination therapy. International journal of cancer\| PubMed ID: 16991124	2006
Identification of the mycobacterial subcomponents involved in the release of tumor necrosis factor-related apoptosis-inducing ligand from human neutrophils. Infection and immunity\| PubMed ID: 17194806	2007
Histone deacetylase inhibitors enhance Ad5-TRAIL killing of TRAIL-resistant prostate tumor cells through increased caspase-2 activity. Apoptosis : an international journal on programmed cell death\| PubMed ID: 17195089	2007
The role of Fas ligand and TNF-related apoptosis-inducing ligand (TRAIL) in the ocular immune response. Chemical immunology and allergy\| PubMed ID: 17264490	2007
Apoptotic cells induce tolerance by generating helpless CD8+ T cells that produce TRAIL. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 17312109	2007
TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma. International journal of radiation oncology, biology, physics\| PubMed ID: 17512128	2007
Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer. Immunologic research\| PubMed ID: 17917057	2007
Predicting bacillus Calmette-Guerin immunotherapy effectiveness. The Journal of urology\| PubMed ID: 17936825	2007
Cytomegalovirus and the role of interferon in the expression of tumor necrosis factor-related apoptosis-inducing ligand in the placenta. American journal of obstetrics and gynecology\| PubMed ID: 18060949	2007
TNF-related apoptosis-inducing ligand (TRAIL) is expressed throughout myeloid development, resulting in a broad distribution among neutrophil granules. Journal of leukocyte biology\| PubMed ID: 18063697	2008
Activation of tumor-specific CD8+ T Cells after intratumoral Ad5-TRAIL/CpG oligodeoxynucleotide combination therapy. Cancer research\| PubMed ID: 18089829	2007
Molecular mechanisms of death ligand-mediated immune modulation: a gene therapy model to prolong islet survival in type 1 diabetes. Journal of cellular biochemistry\| PubMed ID: 18247339	2008
Tumor necrosis factor-related apoptosis inducing ligand-R4 decoy receptor expression is correlated with high Gleason scores, prostate-specific antigen recurrence, and decreased survival in p... Urologic oncology\| PubMed ID: 18312935	2008
High levels of endogenous tumor necrosis factor-related apoptosis-inducing ligand expression correlate with increased cell death in human pancreas. Pancreas\| PubMed ID: 18437085	2008
Role of neutrophils in BCG immunotherapy for bladder cancer. Urologic oncology\| PubMed ID: 18593617	2008
Influenza-induced expression of functional tumor necrosis factor-related apoptosis-inducing ligand on human peripheral blood mononuclear cells. Human immunology\| PubMed ID: 18723061	2008
CD8 T cells utilize TRAIL to control influenza virus infection. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 18802095	2008
High TRAIL death receptor 4 and decoy receptor 2 expression correlates with significant cell death in pancreatic ductal adenocarcinoma patients. Pancreas\| PubMed ID: 18981952	2009
The use of immunofluorescence in microdissection testicular sperm extraction. Journal of andrology\| PubMed ID: 19234316	2009
TRAIL gene therapy: from preclinical development to clinical application. Current gene therapy\| PubMed ID: 19275567	2009
Early microrecanalization of vas deferens following biodegradable graft implantation in bilaterally vasectomized rats. Asian journal of andrology\| PubMed ID: 19349949	2009
[Not Available]. Journal of oncology\| PubMed ID: 19547714	2009
Induction of tumor cell apoptosis by TRAIL gene therapy. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 19565910	2009
Adenovirus-mediated TRAIL gene (Ad5hTRAIL) delivery into pancreatic islets prolongs normoglycemia in streptozotocin-induced diabetic rats. Human gene therapy\| PubMed ID: 19572802	2009
In vivo fluorescence imaging is well-suited for the monitoring of adenovirus directed transgene expression in living organisms. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging\| PubMed ID: 19789926	2010
TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies. European journal of pharmacology\| PubMed ID: 19836385	2009
Activation-induced CD154 expression abrogates tolerance induced by apoptotic cells. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 19841180	2009
TRAIL-deficient mice exhibit delayed regression of retinal neovascularization. The American journal of pathology\| PubMed ID: 19893042	2009
The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Guérin (BCG) immunotherapy for urothelial carcinoma of the bladder. Cancer metastasis reviews\| PubMed ID: 19967427	2009
Bacillus Calmette-Guerin immunotherapy for urothelial carcinoma of the bladder. Immunotherapy\| PubMed ID: 20046960	2009
Sepsis-induced apoptosis leads to active suppression of delayed-type hypersensitivity by CD8+ regulatory T cells through a TRAIL-dependent mechanism. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 20483771	2010
Conatumumab, a fully human mAb against death receptor 5 for the treatment of cancer. Current opinion in investigational drugs (London, England : 2000)\| PubMed ID: 20496264	2010
Micro-recanalization in a biodegradable graft for reconstruction of the vas deferens is enhanced by sildenafil citrate. Asian journal of andrology\| PubMed ID: 20639908	2010
Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist. Apoptosis : an international journal on programmed cell death\| PubMed ID: 20734142	2011
TRAIL-expressing CD8+ T cells mediate tolerance following soluble peptide-induced peripheral T cell deletion. Journal of leukocyte biology\| PubMed ID: 20807702	2010
NF-κB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL. BMC cancer\| PubMed ID: 20977779	2010
Systemic immunological tolerance to ocular antigens is mediated by TRAIL-expressing CD8+ T cells. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 21169546	2011
Tracing of islet graft survival by way of in vivo fluorescence imaging. Diabetes/metabolism research and reviews\| PubMed ID: 21584921	2011
Immune unresponsiveness to secondary heterologous bacterial infection after sepsis induction is TRAIL dependent. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 21788440	2011
Description of a novel murine model for ileocystoplasty and early histologic changes. TheScientificWorldJournal\| PubMed ID: 21789468	2011
Clinical significance of TRAIL and TRAIL receptors in patients with head and neck cancer. Head & neck\| PubMed ID: 21837697	2011
The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 21940678	2011
The plasticity of regulatory T cell function. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 22013112	2011
Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells. Immunity\| PubMed ID: 22035838	2011
Effect of Combined Locally Delivered Growth Factors and Systemic Sildenafil Citrate on Microrecanalization in Biodegradable Conduit for Vas Deferens Reconstruction. Urology\| PubMed ID: 22285175	2012
Eradication of metastatic renal cell carcinoma after adenovirus-encoded TNF-related apoptosis-inducing ligand (TRAIL)/CpG immunotherapy. PloS one\| PubMed ID: 22312440	2012
Diet-induced obesity alters dendritic cell function in the presence and absence of tumor growth. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 22745381	2012
Therapeutic potential of VIP vs PACAP in diabetes. Journal of molecular endocrinology\| PubMed ID: 22991228	2012
Insulin gene therapy from design to beta cell generation. Expert reviews in molecular medicine\| PubMed ID: 23062285	2012
TNF-related apoptosis-inducing ligand (TRAIL) exerts therapeutic efficacy for the treatment of pneumococcal pneumonia in mice. The Journal of experimental medicine\| PubMed ID: 23071253	2012
Activation of systemic antitumor immunity via TRAIL-induced apoptosis. Oncoimmunology\| PubMed ID: 23170271	2012
Sustained and incomplete recovery of naive CD8+ T cell precursors after sepsis contributes to impaired CD8+ T cell responses to infection. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 23355736	2013
PMN and anti-tumor immunity--the case of bladder cancer immunotherapy. Seminars in cancer biology\| PubMed ID: 23410637	2013
T-cell-mediated immunity and the role of TRAIL in sepsis-induced immunosuppression. Critical reviews in immunology\| PubMed ID: 23510024	2013
Clinical utility of insulin and insulin analogs. Islets\| PubMed ID: 23584214	2013
Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer. Cancers\| PubMed ID: 24212631	2011
Intravascular staining for discrimination of vascular and tissue leukocytes. Nature protocols\| PubMed ID: 24385150	2014
Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival. Cell host & microbe\| PubMed ID: 24439895	2014
Polymicrobial sepsis alters antigen-dependent and -independent memory CD8 T cell functions. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 24646738	2014
GLP-1-mediated gene therapy approaches for diabetes treatment. Expert reviews in molecular medicine\| PubMed ID: 24666581	2014
Effective TRAIL-based immunotherapy requires both plasmacytoid and CD8α dendritic cells. Cancer immunology, immunotherapy : CII\| PubMed ID: 24711083	2014
Minimal changes in the systemic immune response after nephrectomy of localized renal masses. Urologic oncology\| PubMed ID: 24768357	2014
Impact of sepsis on CD4 T cell immunity. Journal of leukocyte biology\| PubMed ID: 24791959	2014
CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinoma. Cancer immunology, immunotherapy : CII\| PubMed ID: 25143233	2014
Immunosuppression after sepsis: systemic inflammation and sepsis induce a loss of naïve T-cells but no enduring cell-autonomous defects in T-cell function. PloS one\| PubMed ID: 25541945	2014
Alterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 25595784	2015
The frequency of naive and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuse. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 25972483	2015
Polymicrobial Sepsis Increases Susceptibility to Chronic Viral Infection and Exacerbates CD8+ T Cell Exhaustion. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 25980007	2015
Exploiting natural anti-tumor immunity for metastatic renal cell carcinoma. Human vaccines & immunotherapeutics\| PubMed ID: 25996049	2015
Therapeutic applications of TRAIL receptor agonists in cancer and beyond. Pharmacology & therapeutics\| PubMed ID: 26343199	2015
Triptolide enhances the tumoricidal activity of TRAIL against renal cell carcinoma. The FEBS journal\| PubMed ID: 26426449	2015
Gut Microbial Membership Modulates CD4 T Cell Reconstitution and Function after Sepsis. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 27448587	2016
CD8 T Cell-Independent Antitumor Response and Its Potential for Treatment of Malignant Gliomas. Cancers\| PubMed ID: 27472363	2016
Clinical and Experimental Sepsis Impairs CD8 T-Cell-Mediated Immunity. Critical reviews in immunology\| PubMed ID: 27480902	2016
Enteric immunity, the gut microbiome, and sepsis: Rethinking the germ theory of disease. Experimental biology and medicine (Maywood, N.J.)\| PubMed ID: 27633573	2017
Polymicrobial Sepsis Diminishes Dendritic Cell Numbers and Function Directly Contributing to Impaired Primary CD8 T Cell Responses In Vivo. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 27798171	2016
Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice. Cell death & disease\| PubMed ID: 28055006	2017